WE SERVE ENTREPRENEURS AS VALUED THOUGHT PARTNERS.

We believe coupling talented people with disruptive technologies is a formula for success. We focus on therapeutic medical devices and healthcare diagnostics, information technology, and services platforms that are “with the grain” of healthcare economics – improving patient outcomes while decreasing costs – in markets with significant unmet clinical needs. We pursue opportunities with mitigated technical, regulatory, and financial risk profiles where we can add value beyond our capital in navigating complex operational and regulatory hurdles, accelerating organic revenue growth and margin expansion, and building profitable businesses with a compelling market and patient advantage.

OUR INVESTMENT CRITERIA

“WITH THE GRAIN” TECHNOLOGY Improves patient outcomes while decreasing the cost burden to the healthcare system

SIGNIFICANT CONSUMER NEED Large market opportunity with sustainable high growth prospects

MITIGATED RISK PROFILE Clinically validated products with established regulatory pathways, clear line of sight to revenue, and high margin potential

LATER STAGE FOCUS Real products with a compelling exit strategy

OUR PROCESS

We value your time and promise not to waste it. We are committed to delivering a binary indication of interest within two weeks of our initial review. Opportunities meeting our investment criteria will advance further in our review and diligence process. For opportunities that do not align with our investment criteria, we make every effort to provide valuable and constructive feedback.